[CarolynS]

ACADIA Pharmaceuticals Awarded Grant from The Michael J. Fox Foundation for the Development of Novel Nurr1-RXR Agonists to Treat Parkinson's Disease

http://www.marketwatch.com/story/aca...k=MW_news_stmp

SAN DIEGO, Nov 09, 2010 (BUSINESS WIRE) -- ACADIA Pharmaceuticals Inc, a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it has been awarded a grant from The Michael J. Fox Foundation (www.michaeljfox.org) for the development of novel Nurr1-RXR agonists for the treatment of Parkinson's disease. The grant of $300,000 was awarded under the Foundation's Therapeutics Development Initiative aimed at supporting preclinical development of Parkinson's disease therapies that have the potential for fundamentally altering disease course and improving treatment of symptoms above and beyond current standards of care. This grant represents ACADIA's third award from The Michael J. Fox Foundation.